Boston Scientific (BSX) - Heavy insider buying near 52 week lows

{"summary": "Author argues Boston Scientific is undervalued after a 58% drawdown, citing a cluster of open-market insider purchases as a bullish signal.", "reason": "The author provides a directional thesis based on valuation multiples and a specific catalyst (insider buying cluster) that contradicts recent executive selling.", "ideas": [{"symbol": "BSX", "direction": "long", "thesis": "The author argues Boston Scientific trades at multi-year low valuation multiples after falling over 58% from its 52-week high of $105.65, which conflicts with its underlying operational performance. The catalyst cited is an aggressive cluster of open-market insider purchases between May and August 2026, a complete reversal from routine executive selling in 2025 and early 2026. The author implies insider buying near 52-week lows signals confidence in the company's fundamentals. No explicit risk is stated beyond the sell-off context.", "thesis_short": "Insider buying cluster signals BSX undervalued", "quote": "The recent insider activity in Boston Scientific (BSX) reveals an aggressive cluster of open-market purchases between May and August 2026, marking a complete reversal from the routine executive selling observed in 2025 and early 2026.", "confidence": 0.7, "sentiment": 0.7, "timeframe": "unspecified"}], "model": "gemini-3.1-flash-lite", "failure_count": 0, "verified": true, "extraction_model": "deepseek-flash"}